Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
Year: 2018
Type: article
Abstract: Ability to form cellular aggregations such as tumorspheres and spheroids have been used as a morphological marker of malignant cancer cells and in particular cancer stem cells (CSC). However, the common definition of the types of cellular aggregation formed by cancer cells has not been available. We examined morphologies of 67 cell lines cultured on three dimensional morphology enhancing NanoCulture Plates (NCP) and classified the types of cellular aggregates that form. Among the 67 cell lines, 49 cell lines formed spheres or spheroids, 8 cell lines formed grape-like aggregation (GLA), 8 cell lines formed other types of aggregation, and 3 cell lines formed monolayer sheets. Seven GLA-forming cell lines were derived from adenocarcinoma among the 8 lines. A neuroendocrine adenocarcinoma cell line PC-3 formed asymmetric GLA with ductal structures on the NCPs and rapidly growing asymmetric tumors that metastasized to lymph nodes in immunocompromised mice. In contrast, another adenocarcinoma cell line DU-145 formed spheroids in vitro and spheroid-like tumors in vivo that did not metastasize to lymph nodes until day 50 after transplantation. Culture in the 3D nanoenvironment and in a defined stem cell medium enabled the neuroendocrine adenocarcinoma cells to form slowly growing large organoids that expressed multiple stem cell markers, neuroendocrine markers, intercellular adhesion molecules, and oncogenes in vitro. In contrast, the more commonly used 2D serum-contained environment reduced intercellular adhesion and induced mesenchymal transition and promoted rapid growth of the cells. In addition, the 3D stemness nanoenvironment promoted secretion of HSP90 and EpCAM-exosomes, a marker of CSC phenotype, from the neuroendocrine organoids. These findings indicate that the NCP-based 3D environment enables cells to form stem cell tumoroids with multipotency and model more accurately the in vivo tumor status at the levels of morphology and gene expression.
Source: PLoS ONE
Authors: Takanori Eguchi(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft), Chiharu Sogawa(Data curation, Formal analysis, Investigation, Methodology, Software, Validation), Yuka Okusha(Data curation, Investigation, Software), Kenta Uchibe(Investigation, Methodology), Ryosuke Iinuma(Data curation, Investigation, Resources), Kisho Ono(Investigation, Validation), Keisuke Nakano(Investigation, Methodology, Software), Jun Murakami(Funding acquisition, Resources), Manabu Itoh(Data curation, Methodology, Resources), Kazuya Arai(Investigation, Methodology), Toshifumi Fujiwara(Validation), Yuri Namba(Validation), Yoshiki Murata(Validation), Kazumi Ohyama(Validation), Manami Shimomura(Resources), Hirohiko Okamura(Validation), Masaharu Takigawa(Resources), Tetsuya Nakatsura(Resources), Ken-ichi Kozaki(Resources, Supervision), Kuniaki Okamoto(Resources), Stuart K. Calderwood(Writing – review & editing)
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Awards: 転写因子機能を有するMmp3により発現誘導される新規の癌転移マーカーの探索, Extracellular Hsp70 and hyperthermia in tumor therapy, Development of Novel Assay Systems to Evaluate Drug Sensitivity and Resistance that Reflects Tumor Heterogeneity, Establishment of molecular basis of CCN family proteins for therapeutic use and its related translational research, MZF1-Driven Cancer Stem-Like Resistance Against Cell Stress, Development of prognosis method for oral cancer prognosis with body fluid diagnosis using exosome as an index, Transmembrane Signal Modulation by Hyperthermia, Drug repositioning using the gene promoter activity-based anticancer drug screening system
OpenAlex ID: W2792260527
